Skip to main content
. 2021 Feb 14;166:105472. doi: 10.1016/j.phrs.2021.105472

Table 2.

National authorized guidelines for the prevention and treatment of COVID-19 with traditional medicine (TM)/herbal medicines (HMs) in China, India and South Korea.

Country TM system Guideline Involvement of TM
Recommendation of HMs
Prevention/ Diagnosis & treatment Single herb Herbal formulae Registered herbal preparation
immune enhancement
China Traditional Chinese medicine Guideline for the Diagnosis and Treatment of COVID-19 (Trial 3rd edition)[9]
Guideline for the Diagnosis and Treatment of COVID-19 (Trial 4th edition)[10]
Guideline for the Diagnosis and Treatment of COVID-19 (Trial 5th edition)[11]
Guideline for the Diagnosis and Treatment of COVID-19 (Trial 6th edition)[12]
Guideline for the Diagnosis and Treatment of COVID-19 (Trial 7th edition)[13]
Guideline for the Diagnosis and Treatment of COVID-19 (Trial 8th edition)[14]
India Ayurveda Guidelines for Ayurveda Practitioners for COVID 19[15]
Yoga Guidelines for Yoga Practitioners for COVID 19[16]
Unani Guidelines for Unani Practitioners for COVID 19[17]
Siddha Guidelines for Siddha Practitioners for COVID 19[18]
Homoeopathic Guidelines for Homoeopathic Practitioners for COVID 19[19]
Naturopathy Guidelines for Naturopathy Practitioners for COVID 19[20]
South Korea Traditional Korean medicine COVID-19 Korean medicine clinical guidance (1st edition)[21]
COVID-19 Korean medicine clinical guidance (2nd edition)[22]
A consensus guideline of herbal medicine for coronavirus disease 2019[23]
Guidance on COVID-19 Telemedicine of Korean Medicine[24]